TAIPEI – Taiwan Premier Su Tseng-chang received the AstraZeneca COVID-19 shot on Monday, having volunteered to be first in line to underscore government confidence in the vaccine’s safety as the island began its inoculation campaign.
“I have just finished getting the injection, there is no pain at the injection site, and there is no soreness of the body,” Su told reporters at National Taiwan University Hospital in central Taipei.
“The doctor told me to drink more boiled water and rest a bit. The first point I’ll follow, and the second point may be more difficult. But I’ll still try to rest as much as possible,” he added.
More than a dozen European countries suspended use of the AstraZeneca vaccine last week amid concerns about its safety after reports of a small number of blood disorders. The World Health Organization’s European director said on Thursday the benefits of the shot far outweigh any risks, and its widespread use resumed on Friday.
Taiwan’s first vaccines — 117,000 doses of the AstraZeneca shot — arrived on the island earlier this month from a South Korean factory.
Around 60,000 people are in line to get the first vaccinations and Taiwan is prioritizing health workers.
The first vaccine for a health worker was given at a hospital in New Taipei City, next to the capital Taipei, local media reported.
In December, Taiwan said it had agreed to buy almost 20 million vaccine doses, including 10 million from AstraZeneca.
Taiwan’s government has played down concerns about the late start to the vaccination program, saying that with such a low case rate there is not the urgency that exists in other countries where the pandemic remains rampant.
Only 33 people remain in hospitals being treated for COVID-19 in Taiwan. The island has kept the pandemic well under control thanks to early and effective prevention, including largely closing its borders.
In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.
Your news needs your support
Since the early stages of the COVID-19 crisis, The Japan Times has been providing free access to crucial news on the impact of the novel coronavirus as well as practical information about how to cope with the pandemic. Please consider subscribing today so we can continue offering you up-to-date, in-depth news about Japan.